On the other hand, the mRNA expression level of Bcl-2 in D-CME (P  < 0.05), not in D-CML, was significantly higher than that in the diabetic group. This evidence concerns the gene BCL2 and chronic myelogenous leukemia, BCR-ABL1 positive.